Evidence map›Paper›PMID 19714745›Full record

ArticleInflammatory bowel diseases2010

Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB.

Christian Sina, Alexander Arlt, Olga Gavrilova, Emilie Midtling, Marie-Luise Kruse, Susanne Sebens Müerköster, Rajiv Kumar, Ulrich R Fölsch, Stefan Schreiber, Philip Rosenstiel and 1 more

Open access · greenAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. YTHDF2-mediated mFrontiers in cellular and infection microbiology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Christian Sina *Institute of Clinical Molecular Biology, UKSH-Campus Kiel, Kiel, Germany.
Alexander Arlt *Laboratory of Molecular Gastroenterology & Hepatology, Department of General Medicine, UKSH-Campus Kiel, Kiel, Germany.
Olga GavrilovaInstitute of Clinical Molecular Biology, UKSH-Campus Kiel, Kiel, Germany.
Emilie MidtlingInstitute of Clinical Molecular Biology, UKSH-Campus Kiel, Kiel, Germany.
Marie-Luise KruseLaboratory of Molecular Gastroenterology & Hepatology, Department of General Medicine, UKSH-Campus Kiel, Kiel, Germany.
Susanne Sebens MüerkösterLaboratory of Molecular Gastroenterology & Hepatology, Department of General Medicine, UKSH-Campus Kiel, Kiel, Germany.
Rajiv KumarDepartments of Medicine, Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.
Ulrich R FölschLaboratory of Molecular Gastroenterology & Hepatology, Department of General Medicine, UKSH-Campus Kiel, Kiel, Germany.
Stefan SchreiberInstitute of Clinical Molecular Biology, UKSH-Campus Kiel, Kiel, Germany.
Philip Rosenstiel *Institute of Clinical Molecular Biology, UKSH-Campus Kiel, Kiel, Germany.
Heiner Schäfer *Laboratory of Molecular Gastroenterology & Hepatology, Department of General Medicine, UKSH-Campus Kiel, Kiel, Germany.
Christian-Albrechts-Universität zu Kiel · DEClinical Research Center Kiel · DEMayo Clinic · US

Funding

REGULATIOIN OF RENAL PHOSPHATE EXCRETION AND VITAMIN D METABOLISM BY FGF 7R01DK076829 · NIDDK · MAYO CLINIC ROCHESTER · PI KUMAR, RAJIV · 2007 to 2010
$1.2M
NIDDK NIH HHS R01 DK076829
6 · The paper itself

Abstract

backgroundInflammatory bowel diseases (IBDs) result from environmental and genetic factors and are characterized by an imbalanced immune response in the gut and deregulated activation of the transcription factor NF-kappaB. Addressing the potential role of gly96/iex-1 in the regulation of NF-kappaB in IBD, we used the dextran sodium sulfate (DSS) colitis model in mice in which the gly96/iex-1 gene had been deleted.

methodsC57BL/6 mice of gly96/iex-1(-/-) or gly96/iex-1(+/+) genotype were treated continuously with 4% DSS (5 days) and repeatedly with 2% DSS (28 days) for inducing acute and chronic colitis, respectively. In addition to clinical and histological exploration, colon organ culture and bone marrow-derived cells (BMCs) were analyzed for chemo/cytokine expression and NF-kappaB activation.

resultsCompared to wildtype littermates, gly96/iex-1(-/-) mice exhibited an aggravated phenotype of both acute and chronic colitis, along with a greater loss of body weight and colon length. Colonic endoscopy revealed a higher degree of hyperemia, edema, and bleeding in gly96/iex-1(-/-) mice, and immunohistochemistry detected massive mucosal infiltration of leukocytes and marked histological changes. The expression of proinflammatory chemo- and cytokines was higher in the colon of DSS-treated gly96/iex-1(-/-) mice, and the NF-kappaB activation was enhanced particularly in the distal colon. In cultured BMCs from gly96/iex-1(-/-) mice, Pam(3)Cys(4) treatment induced expression of proinflammatory mediators to a higher degree than in gly96/iex-1(+/+) BMCs, along with greater NF-kappaB activation.

conclusionsBased on the observation that genetic ablation of gly96/iex-1 triggers intestinal inflammation in mice, we demonstrate for the first time that gly96/iex-1 exerts strong antiinflammatory activity via its NF-kappaB-counterregulatory effect.

Indexed as

AnimalsChemokinesColitisColonCytokinesDisease Models, AnimalEnzyme-Linked Immunosorbent AssayImmediate-Early ProteinsMacrophagesMiceMice, Inbred C57BLMice, Mutant StrainsNeutrophilsNF-kappa BReverse Transcriptase Polymerase Chain ReactionT-LymphocytesChemokinesCytokinesIEX-1 protein, mouseImmediate-Early ProteinsNF-kappa B

Identifiers

PMID19714745
PMCPMC3927407
OpenAlexW2000414813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.